To PET or not to PET? That is the question. Staging in anal cancer
Authors:
Open Access
- 31 January 2012
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 23 (8) , 2078-2082
Abstract
Anal cancer is a rare tumour accounting for ∼2% of all colorectal cancers between 1997 and 2000 in the UK. Staging is still dominated by DRE (digital rectal examination), computed tomography (CT) and magnetic resonance imaging (MRI) imaging. The role of PET as a definitive modality is still emerging and there are relatively few adequate studies in the literature. We looked at patients treated radically for anal cancer at Mount Vernon Cancer Centre (UK) between 2009 and 2010. Eighty-eight patients underwent treatment according to data-based coding records of which 46 had positron emission tomography (PET)/CT scans. Notes were unavailable for three patients. We compared staging following conventional modalities (DRE, MRI and CT) and PET/CT scans for these 43 patients. In 18 patients, the PET/CT stage differed from MRI. PET/CT altered the stage in 42% of patients but changes in subsequent management were not implemented. Our data show that PET/CT does alter staging in a significant number of cases although it did not lead to change in management under the current guidelines. Furthermore, there is agreement that PET/CT shows greater sensitivity for detection of lymph nodes and our study has demonstrated a distinct trend towards upstaging of anal cancer with PET/CT.Keywords
This publication has 11 references indexed in Scilit:
- FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinomaRadiation Oncology, 2010
- Anal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancerBritish Journal of Cancer, 2009
- ACT II: The Second UK Phase III Anal Cancer TrialClinical Oncology, 2005
- Positron Emission Tomography for Pretreatment Staging and Posttreatment Evaluation in Cancer of the Anal CanalMolecular Imaging and Biology, 2005
- Prospective Evaluation of Positron Emission Tomography for the Detection of Groin Node Metastases from Vulvar CancerGynecologic Oncology, 2002
- Metastatic Lymph Nodes in Patients with Cervical Cancer: Detection with MR Imaging and FDG PETRadiology, 2001
- Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.Journal of Clinical Oncology, 1997
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 casesHistopathology, 1990